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Abstract
St. Louis encephalitis virus (SLEV; Flaviviridae, flavivirus) was the major cause of epidemic flaviviral encephalitis in the U.S.
prior to the introduction of West Nile virus (WNV) in 1999. However, outbreaks of SLEV have been significantly more limited
then WNV in terms of levels of activity and geographic dispersal. One possible explanation for these variable levels of
activity is that differences in the potential for each virus to adapt to its host cycle exist. The need for arboviruses to replicate
in disparate hosts is thought to result in constraints on both evolution and host-specific adaptation. If cycling is the cause of
genetic stability observed in nature and arboviruses lack host specialization, then sequential passage should result in both
the accumulation of mutations and specialized viruses better suited for replication in that host. Previous studies suggest
that WNV and SLEV differ in capacity for both genetic change and host specialization, and in the costs each accrues from
specializing. In an attempt to clarify how selective pressures contribute to epidemiological patterns of WNV and SLEV, we
evaluated mutant spectra size, consensus genetic change, and phenotypic changes for SLEV in vivo following 20 sequential
passages via inoculation in either Culex pipiens mosquitoes or chickens. Results demonstrate that the capacity for genetic
change is large for SLEV and that the size of the mutant spectrum is host-dependent using our passage methodology.
Despite this, a general lack of consensus change resulted from passage in either host, a result that contrasts with the idea
that constraints on evolution in nature result from host cycling alone. Results also suggest that a high level of adaptation to
both hosts already exists, despite host cycling. A strain significantly more infectious in chickens did emerge from one
lineage of chicken passage, yet other lineages and all mosquito passage strains did not display measurable host-specific
fitness gains. In addition, increased infectivity in chickens did not decrease infectivity in mosquitoes, which further contrasts
the concept of fitness trade-offs for arboviruses.
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Introduction
St. Louis encephalitis virus (SLEV) is a member of the genus
flavivirus, family Flaviviridae. SLEV is a close relative of West Nile
virus (WNV) and other members of the Japanese encephalitis
serocomplex [1]. Like WNV, SLEV is predominantly maintained
in a transmission cycle between ornithophilic mosquitoes and
birds. The dominant vectors of both SLEV and WNV in N.
America are mosquitoes in the Culex genus [2,3]. SLEV was the
major cause of epidemic flaviviral encephalitis in the United States
prior to the introduction of WNV into North America. More than
4,600 human infections were reported between 1964 and 2005
[4]. However, since its emergence in the United States in 1999,
WNV has spread to 48 states and caused illness in more than
20,000 humans (http://www.cdc.gov/ncidod/dvbid/westnile/
surv and control.htm). Although SLEV has occasionally been
transported between geographic regions both within and outside
the U.S. [5,6], phylogenetic analyses indicate that SLEV is
predominantly maintained locally, with strains generally clustering
according to geographic origins [7]. Understanding the more
contained nature of SLEV activity relative to that of the
widespread dissemination of WNV could be potentially important
in determining the factors which are significant in dictating the
breadth of arbovirus activity in general.
The need for arboviruses to replicate in disparate hosts is often
thought to result in constraints on both evolution and host-specific
adaptation. This hypothesis is consistent with the fact that the
magnitude of genetic change observed with arboviruses in nature
has generally not been consistent with the enormous potential for
change inherent to RNA viruses [8]. If differing selective pressures
resulting from cycling are the cause of genetic stability observed in
nature, then sequential passage in a single host species should result
in the accumulation of mutations which otherwise would be
purged. Studies done previously with WNV demonstrate that
significant intrahost genetic diversity is generated with both
sequential and alternate in vivo passage; and the source of this
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selection in mosquitoes [9,10]. These studies, which also show no
difference in the number of mutations fixed in alternate and
sequentially passaged populations, do not necessarily support the
idea of a dampened rate of genetic change as a consequence of host
cycling. Here, in an attempt to begin to clarify the role of selective
pressures in the differing epidemiological patterns of WNV and
SLEV, we evaluated both host-specific mutant spectra size and
consensus genetic change for SLEV following sequential passage in
either Culex pipiens Linneaus mosquitoes or chickens. Previous
studies in mosquito cell culture suggest SLEV may produce and
maintain much more limited intrahost mutant spectra relative to
WNV during sequential passage [11]. Differing levels of genetic
diversity in nature could contribute to differences in adaptability of
virus populations and, consequently, differences in host and
geographic range, as well as in overcoming seasonal bottlenecks.
Beyond this, minority sequences have been clearly implicated in
contributing to other phenotypes including both viral fitness and
viral pathogenesis [9,12–14]. Evolutionary theory also would
predict that arboviruses need to be generalists in order to replicate
in vastly different environments, and that the cost of this generalism
would be suboptimal adaptation to each individual host [15]. If this
were the case, sequential passage in a single host as completed here
also should result in a more specialized virus which is better suited
for replication in that host. Previous studies with both alpahviruses
[16,17–19] and flaviviruses [11,20] have demonstrated host
specialization with passage, yet previous passage of SLEV in Cx.
pipiens demonstrated a lack of adaptation in Cx. pipiens [21]. In those
studies 10 plaque forming units (pfu) of secreted virus from a single
day was used for passaging. Here, in order to (a) allow for direct
comparison to previous WNV studies assessing mutant spectra sizes
[9], and (b) determine if a larger, more diverse population passage
enabled further adaptation, we passaged 100 pfu of virus from the
entire mosquito. Similar in vivo passage of WNV demonstrated that
further adaptation to Cx. pipiens mosquitoes was attainable, yet no
measurable cost resulted in avian hosts in terms of levels and rates
of viremia production. These results, together with previous in vitro
studies suggest that even with host specialization, WNV may retain
its status as a generalist [11]. This idea of the absence of a
significant fitness trade-off has also been demonstrated in studies
with vesicular stomatitis virus (VSV) [22,23]. On the other hand, in
vitro results with SLEV do demonstrate a cost in some hosts as a
result of specialization [11]. By continuing to assess these
characteristics in vivo we can begin to determine the genetic
correlates of host range and specialization and, therefore, shed light
on understanding factors that influence variation in arbovirus
evolution and activity in nature.
Methods
Ethics Statement
All animal use was approved by the Wadsworth Center
Institution of Animal Care and Use Committee (06-355).
Experimental Hosts
Cx. pipiens egg rafts were collected in Pennsylvania in 2004 and
colonized at the Wadsworth Center insectary facilities. Mosquito
rearing and preparation for experimentation were carried out as
previously described [9,11]. White leghorn chickens (Gallus gallus)
used for experimental passage were received from Charles River
breeding labs (Boston, MA). Pathogen-free chicken eggs were
obtained from Sunrise Farms (Catskill, NY), hatched in an
incubator (G.Q.C) at the Arbovirus Laboratories, Wadsworth
Center, and used for experimentation following hatching.
Chickens were housed in metal cages with individual light sources
and daily fresh food, water, and resting pads.
Viruses
A biological clone of SLEV strain Kern (217.3.1.1) was used for
commencement of passage studies and as a control (SLEV P0) in
subsequent experimentation. The clone was isolated by three rounds
of plaque purification on Vero cells and was derived from the SLEV
Kern 217 isolated in 1989 from Culex tarsalis from Kern County, CA
(obtained from Dr. William Reisen, University of California at
Davis;[7]. It has previously been demonstrated that growth kinetics
of SLEV P0and the wildtype SLEV Kern 217 are similar inall hosts
(data not shown). Virus strains derived from passage are denoted as
either mosquito-passaged (SLEV MP) or chicken-passaged (SLEV
CP) together with the number of passages completed.
Experimental Passage
Sequential passages were carried out 20 times in either chickens
or Cx. pipiens mosquitoes using SLEV P0. Four (mosquito) or five
(chicken) separate lineages were maintained throughout passage
(A–E). Passage in mosquitoes was carried out by intrathoracic
inoculation of 0.1 ul as previously described [9,24]. Four female
mosquitoes, 4–7 days old, were inoculated with 100 pfu for each
lineage at every passage. At 7 days post inoculation (p.i.) whole
mosquitoes were placed into 2.0 ml microcentrifuge tubes with
1 ml mosquito diluent (MD; 20% heat-inactivated fetal bovine
serum [FBS] in Dulbecco’s phosphate-buffered saline plus 50 mg/
ml penicillin/streptomycin, 50 mg/ml gentamicin, and 2.5 mg/ml
Fungizone) plus one 5 mm BB (Daisy, Rogers, Arkansas). Samples
were homogenized for 30 seconds at 20 Hz in a Mixer Mill
MM301 (Retsch, Haan, Germany). Debris was then pelleted by
centrifugation at 10,000 rpm for 5 minutes and titrated by plaque
assay in duplicate on Vero cells as previously described [25]. The
highest titer sample from each lineage was diluted and used for
subsequent passage (Fig. 1).
Figure 1. Viral load of individual lineages of SLEV during
sequential passage in chickens (A) or mosquitoes (B).
doi:10.1371/journal.pone.0007876.g001
In Vivo Passage of SLEV
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inoculation of two 5-day old chickens per lineage with 100 ul of
virus passage as previously described [21]. At two days p.i.,
animals were anesthetized using 100 ul Sleepaway (Fort Dodge
Animal Health, Fort Doge, IA) and blood collected by cardiac
puncture using 3 ml serum separator tubes (Fisher healthcare,
Houston, TX) after which chickens were euthanized. Serum was
obtained by spinning whole blood at 4500 r.c.f. for 15 min, and
subsequently titrated by plaque assay in duplicate on Vero cells.
The highest titer sample from each lineage was appropriately
diluted and used for subsequent passage (Fig. 1).
Viral Growth Kinetics and Infectivity in Mosquitoes
Female Cx. pipiens were infected by intrathoracic inoculation for
both determination of infectious dose-50 (ID50; dose at which 50%
of experimental hosts become infected) and growth of individual
virus strains. The ID50 for each SLEV strain was determined by
inoculation of 10–25 mosquitoes per dilution using ten-fold
increasing concentrations of virus from 0.1 pfu, and screening
for infection by plaque assay on Vero cell culture at 7 days p.i.
Calculations of ID50 were done using the Reed-Muench formula.
Inoculations for mosquito growth kinetics were done with 100 pfu
and viral titer was determined for 8–10 mosquitoes/timepoint.
Mosquitoes for both assays were collected and treated as
previously described for experimental passage [21].
Viremia Kinetics and Infectivity in Chickens
One-day old chickens hatched on-site were used for experi-
mentation following passage. For viremia determination, chickens
were inoculated s.c. with 10 pfu of virus and bled from the
brachial vein on days 1–5 p.i. as previously described [21]. Whole
blood was processed as described in passage methodology and
viral titers were used to generate viremia curves. For ID50
experiments, 5–6 chickens/dose were inoculated s.c. with 10, 1.0,
0.1, or 0.01 pfu. At day 14 p.i., chickens were bled by cardiac
puncture, after which chickens were euthanized, and serum was
obtained. Serum was tested for the presence of WNV-specific
antibody using the plaque reduction neutralization test (PRNT) as
previously described [26,27]. The proportion of infected chickens
for each dose was determined and calculations of ID50 were done
using the Reed-Muench formula.
Molecular Cloning and Population Analysis
Production and analysis of clones was performed basically as
previously described [12,28]. RNA was extracted from infected
specimens with Qia-amp viral RNA extraction kit (Qiagen,
Valencia, CA) and RT-PCR was conducted using primers
designed to amplify the 39 1302 nt of the SLEV envelope (E)
coding region and the 59 3325 nt of the SLEV non-structural
protein 1 (NS1) coding region. RT of 5 ml RNA was performed
with Sensiscript RT (Qiagen) at 45uC for 40 min. RT reactions
were followed by heat inactivation at 95uC for 5 min. The
resulting cDNA was used as a template for PCR amplification.
SLEV cDNA was then amplified with a ‘high-fidelity’ protocol
using PfuUltra (published error rate =4.3610
27; Stratagene, La
Jolla, CA), according to the manufacturer’s specifications.
Amplification was carried out for 40 cycles at 94uC for 30 sec,
50uC for 30 sec and 72uC for 4 min, and one cycle at 72uC for
10 min. PCR products were visualized on a 1.5% agarose gel and
DNA was recovered by using a MinElute Gel Extraction kit
(Qiagen) as specified by the manufacturer. The recovered DNA
was ligated into the cloning vector pCR-Blunt II-TOPO
(Invitrogen, Carlsbad, CA) and transformed into One Shot
TOP10 Electrocomp E.coli cells according to the manufacturer’s
protocol. Kanamycin resistance was used for initial detection of
transformed colonies. Colonies were then screened by direct PCR
using primers specific for the desired insert. Plasmid DNA was
purified by using a QIAprep Spin Miniprep kit (Qiagen) as
specified by the manufacturer. Sequencing was carried out by
using five pairs of overlapping SLEV primers together with T7
and SP6 primers. Sequencing was performed at the Wadsworth
Center Molecular Genetics Core using ABI 3700 and 3100
automated sequencers (Applied Biosystems, Foster City, CA).
Fifteen to twenty-four clones per sample were sequenced.
Sequences were compiled, edited, and aligned using DNASTAR
software package (Madison, WI). Individual clones were compared
to consensus sequences as previously described [12]. The
percentage of nucleotide mutations (total number of mutations
divided by total number of bases sequenced), amino acid
mutations (total number of amino acid changes divided by total
number of amino acids sequenced), and the sequence diversity
(percent of clones with at least one difference from consensus) were
used as indicators of genetic diversity. Normalized Shannon
entropy (Sn) was calculated based on frequency of genotypes in
populations as follows: Shannon entropy (Sn)=g-i Pi lnPi/ln N,
where Pi = frequency of individual genotype and N = number of
clones sequenced. Sn values range from 0 (completely homoge-
neous) to 1(completely heterogeneous).
Full-Genome Sequencing
RNA was extracted from SLEV using RNeasy (Qiagen,
Valencia, CA) according to manufacturer’s protocol and sequenc-
ing was carried out as previously described [29]. One-step RT-
PCR (Qiagen) was conducted using primers to generate nine
overlapping PCR products. Reverse transcription reactions were
carried out at 50uC for 30 min, followed by inactivation of the
transcriptase at 95uC for 15 min. Amplification was then carried
out for 40 cycles at 94uC for 20 sec, 55uC for 30 sec, 72uC for
2 min, with final elongation at 72uC for 10 min. PCR products
were visualized on a 1.5% gel and then bands were then allowed to
run through 1% Nusieve GTG low-melting agarose (Cambrex
BioScience, Rockland, ME). Sequencing was performed with ABI
3700 automated sequencers (Applied Biosystems, Foster City, CA)
using overlapping primers with a minimum of two-fold redun-
dancy. Sequences were compiled and edited by using DNASTAR
software package (Madison, WI).
Results
Intrahost Genetic Diversity during In Vivo Passage
Intrahost genetic diversity of SLEV was determined before
(SLEV P0) and after 0, 1(2), 5, 10, 15, and 20 passages in Cx. pipiens
mosquitoes (MP) or chickens (CP) in order to assess fluctuations in
the size of the mutant spectrum accrued during sequential in vivo
passage. Three lineages (A, B, and C) were evaluated for both MP
and CP strains to provide an accurate representation of the size of
the host-specific mutant spectra. Intrahost diversity of chicken-
passaged lineage D (CP20D) also was evaluated following
identification of unique phenotypic changes. Genetic diversity,
i.e., nt and aa variation, was generally higher during passage in
mosquitoes than during passage in chickens (Figs. 2 and 3). Mutant
spectra size expanded for 10 (lineage A and B) or 15 (C) mosquito
passages, followed by subsequent purification of the population by
passage 15 or 20, respectively (Fig. 2). Amino acid diversity
demonstrated the same general trend as nt diversity and much of
the variation among lineages was reduced when aa diversity is
evaluated on the level of sequence variation (aa Sn; Fig. 3).
Following 20 passages approximately 20.0% of sequences
In Vivo Passage of SLEV
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sequence in the region analyzed. The peak nt diversity (0.066%),
nt sequence entropy (0.72), aa diversity (0.088%), and aa sequence
entropy (0.50) for mosquito-passaged strains was measured with
lineage C at passage 15. This level of genetic diversity is equivalent
to an average of seven nt changes relative to the consensus
Figure 2. Intrahost nucleotide diversity of bases 1315–3325 for individual lineages of SLEV during sequential passage in chickens
or mosquitoes. Nt diversity is equivalent to the total # of mutations relative to the consensus/total # of bases sequenced. Sn(nt) refers to
normalized Shannon entropy based on the frequency of individual genotypes.
doi:10.1371/journal.pone.0007876.g002
Figure 3. Intrahost amino acid diversity for individual lineages of SLEV during sequential passage in chickens or mosquitoes. AA
diversity is equivalent to the total # of amino acid substitutions relative to the consensus/total # sequenced. Sn(aa) refers to normalized Shannon
entropy based on the frequency of individual amino acid genotypes.
doi:10.1371/journal.pone.0007876.g003
In Vivo Passage of SLEV
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being nonsynonomous.
Mutant spectra size during passage of SLEV in chickens was
highly variable among lineages using all measures of diversity
(Figs. 2 and 3). Lineage C remained highly homogeneous
throughout passage, while lineages A and B displayed fluctuations
from passage 2 to passage 20. Mean nt diversity peaked at passage
20 (0.021%) despite a lack of variation in lineage C. The peak nt
diversity(0.036%) and nt sequence entropy (0.55) for chicken-
passaged SLEV was measured in lineage B after 10 passages, yet
the peak aa diversity (0.047%) and aa sequence entropy (0.34) was
observed in passage 20 of lineage D.
Consensus Sequencing
Full-genome sequences of SLEV before (P0) and after (MP20A,
MP20B, CP20A, CP20B, and CP20D) passage were generated
and compared in order to determine the extent of fixed, consensus
change which occurred as a result of passage in each host.
Although variation between lineages existed, overall consensus
level change following passage was limited (table 1). For both
SLEV MP20B and CP20B, in fact, other than a mixed population
identified at a single site (A8057R and C2025Y, respectively), no
consensus change was identified. In addition, just a single
substitution was identified in SLEV CP20A (G2845A), resulting
in highly conservative arginine to lysine amino acid substitution in
the NS1 gene. SLEV MP20A and CP20D were slightly more
variable with 6 and 4 nt substitutions respectively, resulting in 4
(MP20A) and 2 (CP20D) amino acid changes. In addition, a mixed
population was identified at a single position in MP20A (A5695R).
All amino acid changes were fairly conservative, with the
exception of the A6981G nt substitution which resulted in arginine
(charged polar) to glycine (nonpolar) amino acid change in the
NS4B gene. Surprisingly, this change was identified in both
MP20A and CP20D.
Viral Growth Following Vertebrate Passage
SLEV titers during passage were variable among lineages and
passage number, but overall did not display any trend toward
increasing or decreasing titer as a result of passage (Fig. 1).
Changes in plaque morphology on Vero cell culture were
observed, with a general increase in plaque size noted for all
lineages, most notably in SLEV CP20D (data not shown).
In order to quantify changes in viral growth kinetics in chickens
following passage, viremia levels were measured on days 1–5 p.i. of
SLEV before (P0) and after (CP20B and D) passage in chickens.
Viral titers of inputs for chicken viremia experiments were
approximately 10 pfu for all groups, and did not significantly
differ from each other. Results demonstrate that, overall, growth
kinetics were similar before and after passage (Fig. 4). For CP20B,
no statistical difference was measured at any timepoint relative to
SLEV P0 (t-test, p.0.05). Despite this, at all timepoints p.i., mean
viremia levels were higher for CP20B and some uncharacteristi-
cally high viremia levels were measured in individual chickens
infected with this strain. For instance, at days 2 and 3 p.i. viremia
levels of 6.90 and 7.30 log10 pfu/ml, respectively, were measured
in a single chicken infected with CP20B. The highest individual
levels of viremia measured on days 2 and 3 p.i. for a chicken
infected with SLEV P0 were 5.81 and 6.45 log10 pfu/ml,
respectively. No individual chickens infected with CP20D
demonstrated such high levels of viremia on days 2 and 3 p.i.,
yet significantly elevated day 1 viremia levels were measured in
this group relative to SLEV P0 (3.70 vs. 2.64 log10 pfu/ml; t-test,
p=0.01). Beyond day 1 p.i. viremia levels were similar for SLEV
CP20D and SLEV P0.
Viral Growth Following Invertebrate Passage
SLEV titers were comparable throughout passage and among
lineages, with no indication of increasing or decreasing viral load
Table 1. Consensus sequence changes of SLEV following
passage in chickens (CP) or Cx. pipiens mosquitoes (MP).
Strain nt change aa change location
SLEV MP20A G1635A none ENV
G1663A R552H ENV
A3107G none NS1
T5659A F1854Y NS3
A5695R(A/G) K1866R NS3
C6583T A2162V NS4A
A6981G R2295G NS4B
SLEV MP20B A8057R(A/G) none NS5
SLEV CP20A G2845A R916K NS1
SLEV CP20B C2025Y(T/C) none ENV
SLEV CP20D C866T none M
A6981G R2295G NS4B
A7971G K2625Q NS5
G8084A none NS5
doi:10.1371/journal.pone.0007876.t001
Figure 4. SLEV viremia kinetics in 1-day old chickens before (P0) and after (CP20) passage in chickens. Data points represent means of
4–5 chickens +/2 S.D. Statistically significance differences are indicated by an asterisk (t-test, p,0.05).
doi:10.1371/journal.pone.0007876.g004
In Vivo Passage of SLEV
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morphology on Vero cell culture were noted with some increases
in plaque heterogenity resulting from the appearance of some
smaller plaques in all lineages. On average, alterations in plaque
morphology were much more pronounced in chicken-passaged
SLEV (data not shown).
Viral titers were determined following IT inoculation of Cx.
pipiens before (P0) and after (MP) 20 passages in Cx. pipiens in order
to evaluate the extent to which mosquito passage altered SLEV
growth kinetics. Experiments were done in parallel and input titers
for each strain tested were equivalent (100 pfu). Overall, growth
kinetics were generally similar before and after passage, indicating
no substantial change in replicative ability as a result of passage
(Fig. 5). Despite this, significant differences between P0 and MP
virus strains were measured at some individual timepoints (Fig. 5;
t-test, p,0.05). Of these, just one MP strain on a single day
showed a significantly higher viral titer than SLEV P0 (SLEV
MP20A day 1; p,0.05). All other differences measured between
SLEV P0 and MP strains indicated significantly lower titers for
MP relative to P0 (days 1–4 p.i.; p,0.05). Taken together, these
results demonstrate that on average initial rate of growth is lower
for MP strains, yet the inconsistency between strains and
timepoints calls into question the biological significance of these
differences. Beyond day 6 p.i. all titers are statistically similar.
Virus Infectivity In Vivo
In order to assess possible changes in virus infectivity resulting
from passage, infection rate at various doses and ID50 of SLEV
were determined in chickens or mosquitoes before and after
passage (tables 2 and 3). A single lineage of chicken-passaged
SLEV (CP20D) was selected for infectivity testing in chickens as a
result of the elevated day 1 p.i. viremia levels relative to SLEV P0
(Fig. 4). Results indicate significantly higher proportions of
chickens infected at 1.0 and 0.1 pfu for SLEV CP20D relative
to SLEV P0 (Chi-squared, p,0.05). The 0.01 pfu dose of SLEV
P0 was not evaluated in chickens due to the fact that no infection
occurred at the next higher dose (0.1 pfu), yet two of six chickens
infected with 0.01 pfu of SLEV CP20D did become infected
(33.3%; table 2). Calculation of ID50 from these data indicated
SLEV CP20D was approximately 30-fold more infectious than its
parental strain (P0) prior to chicken passage (0.03 pfu v. 0.96 pfu;
table 2). In order to determine if increased infectivity in chickens
resulted in a compromised ability to infect mosquitoes, infectivity
of SLEV CP20D was also assessed in Cx. pipiens mosquitoes.
Results indicated no significant differences in infection rates at any
dose (Chi-squared, p.0.05) and equivalent ID50 values for SLEV
before and after chicken passage (table 3). Similar to growth
kinetics results, mosquito-passaged SLEV (MP20A and MP20B)
also showed no significant change in Cx. pipiens infectivity as a
result of passage (table 3). Although infection rates were slightly
higher for SLEV MP20A or B relative to SLEV P0 at some doses,
no differences were statistically different (Chi-squared, p.0.05)
and ID50 values were equivalent (table 3).
Discussion
SLEV is maintained in nature by cycling between Culex species
mosquitoes and avian hosts. Although it has been successfully
established in the U.S. since its isolation in 1933, SLEV has never
reached levels of activity observed in recent years with WNV
despite the genetic and ecological similarities between these two
viruses (www.cdc.gov/ncidod/dvbid; [30]). In fact, it has been
suggested that SLEV has been displaced by WNV from a number
of locations [31]. It is hypothesized that the need for arboviruses to
replicate in divergent vertebrate and invertebrate hosts has
constrained both evolution and host-specific adaptation yet,
despite numerous studies testing this hypothesis, the specifics of
the selective pressures and evolutionary trade-offs which shape
arbovirus evolution are still poorly understood. Much of this
knowledge gap stems from the fact that virus-specific differences
clearly exist; and attempting to apply universal explanations for
arbovirus evolution based on experimental results has proven
difficult [11,16,18,20,22]. Beyond this, the majority of the
experimental evolution studies have been done in cell culture
systems which are generally not accurate models of natural host
systems. In vitro studies are highly useful tools in establishing and
testing hypotheses, yet it is in vivo studies that will ultimately
Figure 5. SLEV growth kinetics in Cx. pipiens mosquitoes before
(P0) and after (MP20) passage in Cx. pipiens mosquitoes. Data
points represent means of 8–10 mosquitoes +/2 S.D. Statistically
significance differences are indicated by an asterisk (t-test, p,0.05).
doi:10.1371/journal.pone.0007876.g005
Table 2. Proportion of chickens infected following
inoculation of 10-fold dilutions of SLEV before (P0) and after
(CP) passage in chickens.
Strain 10.0 pfu 1.0 pfu 0.1 pfu 0.01 pfu ID50
1
SLEV PO 6/6 (100%) 3/6 (50%) 0/6 (0%) - 0.96
SLEV CP20D 6/6 (100%) 6/6 (100%)* 4/6 (67%)* 2/6 (33%) 0.03
*Chi-squared, p,0.05.
1Calculated using Reed-Muench formula.
doi:10.1371/journal.pone.0007876.t002
Table 3. Proportion of Cx. pipiens mosquitoes infected
following inoculation of 10-fold dilutions of SLEV before (P0)
or after passage in mosquitoes (MP) or chickens (CP).
Strain 10.0 pfu 1.0 pfu 0.1 pfu 0.01 pfu ID50
1
SLEV PO 15/15 (100%) 13/15 (87%) 18/25 (72%) 0/10 (0%) 0.05
SLEV MP20A 15/15 (100%) 15/15 (100%) 14/21 (67%) 1/7 (14%) 0.05
SLEV MP20B 15/15 (100%) 13/15 (87%) 16/21 (76%) 1/7 (14%) 0.05
SLEV CP20D 15/15 (100%) 13/15 (87%) 14/20 (70%) 1/10 (10%) 0.05
1Calculated using Reed-Muench formula.
doi:10.1371/journal.pone.0007876.t003
In Vivo Passage of SLEV
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arbovirus evolution in nature. Other than limited studies with Ross
River virus [32], Venezuelan equine encephalitis virus (VEEV;
[19], and WNV [9,10,21], in vivo evaluation of arbovirus evolution
in the laboratory is still lacking. Here, in an effort to expand on
these limited studies we evaluated genetic and phenotypic changes
of SLEV resulting from sequential passage in Cx. pipiens
mosquitoes or chickens. If host cycling does in fact restrict genetic
change and host-specific adaptation as hypothesized then
sequential passage as completed here should result in significant
accumulation of mutations and measurable gains in host-specific
fitness. Virus titers during passage in mosquitoes or chickens did
not indicate any substantial gains in viral load at the time of
harvest (Fig. 1). Although there were fluctuations in viral titers over
time and among lineages for chicken-passaged SLEV, there was
no consistent trend observed. In addition, viral growth kinetics
following passage in general was not consistent with any
substantial gains in replicative fitness (Figs. 3 and 4). It is possible
that direct competition assays may have revealed more subtle
differences in viral fitness, yet previous in vitro studies suggest that
individual growth kinetics are a sufficient screen for identifying
significant gains in replicative fitness [11]. In chickens, although
significantly higher viremia levels were not measured on any day
p.i. for the SLEV CP20B infected chickens as a group, it is notable
that some individual chickens did in fact display viremia titers
which were more elevated than levels typically observed for SLEV
replicating in chickens (Fig. 4). Variation among viral titers in
chickens is normal following infection with SLEV, yet the fact that
the highest levels were seen in the SLEV CP20B group exclusively
suggests more adapted genetic variants may have emerged in those
particular chickens. Although a lack of consensus change was
observed for SLEV CP20B (table 1), this strain did possess a
substantial mutant spectrum at passage 20 and it is therefore
feasible that some minority variants were more suited for avian
replication (Fig. 2). For SLEV CP20D, significantly higher viremia
was measured on day 1 p.i. only (Fig. 4). Infectious dose
experiments confirmed that this difference could be attributed to
a greater than 30-fold increase in infectivity resulting from chicken
passage (table 2). These results, together with the observation that
plaque size on mammalian cell culture was on average larger
following chicken passage, suggest that although SLEV is already
highly adapted to its avian host, some further vertebrate-specific
adaptation is certainly attainable.
The finding of equivalent mosquito infectivity for CP20D
(table 3) demonstrates that such adaptation does not necessarily
come at a cost in the alternate host as would be predicted by
evolutionary theory [15]. This lack of fitness trade-off has been
observed previously with VSV in vitro [22,23], SLEV and WNV in
vitro [29] and WNV in vivo [21], but stands in contrast to studies
with the alphaviruses Sindbis virus, VEEV, and EEEV [16,17–19]
and to recent in vitro studies with Dengue virus [20]. Taken
together, these previous and current results clearly demonstrate
that individual mutations that accumulate during host specializa-
tion may result in a range of phenotypes in other hosts, including
those which are beneficial, neutral, or deleterious. A recent study
with VSV demonstrates that mutations in particular regions of the
genome are linked to fitness tradeoffs while other mutations may
not be [33]. In mosquitoes, viral growth after passage demon-
strated that, with the exception of a single lineage on day 1 p.i.,
virus titers were either lower or statistically similar to the parental
strain (Fig. 4). These results are consistent with previous studies in
our laboratory using only SLEV ejected in the salivary secretion of
Cx. pipiens for passaging [21] and further demonstrate that
additional adaptation in terms of replicative ability is not
attainable for SLEV in Cx. pipiens mosquitoes using these methods.
In addition, infectious dose experiments demonstrate that
increased infectivity in mosquitoes was also not achieved through
sequential passage (table 3).
An important caveat of these experiments is the fact that
intrathoracic inoculation rather than infection of midgut cells via
bloodfeeding is used for both passage and growth kinetics
experiments. It is certainly possible that optimization for infection,
replication, and egress from midgut tissue is much different than
optimization for infection and replication in exterior tissues, yet
achieving adequately high titers for mosquito infection via
bloodfeeding in the absence of intermediate amplification is
problematic and, therefore, this passage methodology is not
feasible. Despite this, the current studies provide more insight than
previous in vitro studies and demonstrate that suboptimal
adaptation in the mosquito is not necessarily a consequence of
host cycling for SLEV. These results stand in contrast to previous
studies with WNV, which displayed increased infectivity and
replicative ability following passage in Cx. pipiens [21]. Phenotypic
results overall suggest that in spite of cycling high levels of
adaptation to both hosts exist for SLEV, yet the result that some
potential exists for further adaptation to the vertebrate but not the
invertebrate suggests, not surprisingly, that the two are likely not
equal partners in virus evolution. In vitro studies with VSV suggest
that the more persistant phase of the transmission cycle (the
invertebrate) may dominate arbovirus evolution [23]. Similarly, in
vivo studies with WNV demonstrate that the large mutant spectra
generated during mosquito infection are maintained during host
switching [10]. As with these previous WNV studies, results here
suggest that the main source of genetic variation for SLEV is the
mosquito (Figs. 2 and 3). Variation among lineages in terms of
nucleotide diversity during chicken passage makes determination
of representative mutant spectrum size and clear evaluation of
selective pressures difficult. Despite this, analysis of change on the
amino acid level demonstrates that sequence variation is generally
modest in the avian host. Conversely, levels of genetic variation
generated in the mosquito were relatively high and generally
consistent among lineages (Figs. 2 and 3). Peak SLEV diversity in
the mosquito was in fact higher than levels previously measured in
similar studies with WNV [9]. These results stand in contrast to
previous in vitro studies suggesting that the capacity for genetic
change of SLEV may be less than that of WNV in mosquitoes, yet
in cell culture studies SLEV became highly adapted to the
experimental host while here it did not [11].
Differences in genetic diversity generated in the two hosts in vivo
can likely be attributed to a combination of differing selective
pressures and levels of replication. In the mosquito, what remains
unclear is how both neutral and selective bottlenecks within the
host specifically affect the size and composition of the viral swarm
that is ultimately transmitted. Previous studies with WNV
demonstrate that virus sequentially passed using salivary secretions
is highly homogeneous, suggesting diversity may be purged prior
to transmission [21]. The level of consensus change measured
among lineages here was variable (table 1), yet the fact that one of
two mosquito and two of three chicken lineages accrued just a
single base substitution in the entire genome does not support the
idea that cycling leads to considerable dampening of fixed
sequence change and, therefore, rates of evolution. Consensus
amino acid changes that did occur were by in large conservative
changes (table 1). One exception was an Arginine (charged polar)
to Glycine (nonpolar) change at position 2295 of the NS4B gene.
Surprisingly, this change was identified in both SLEV MP20A and
SLEV CP20D. It would seem improbable that the same change
would be selected for in completely divergent hosts unless it
In Vivo Passage of SLEV
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measurable gains for SLEV MP20A in mosquitoes it seems likely
that this variant already existed in the SLEV P0 mutant swarm
prior to passage and that its phenotypic impact is limited.
Taken together, these results indicate that, although there are
clearly differing selective pressures in the avian and mosquito
portion of the SLEV life cycle, a high level of adaptation exists in
both vertebrate and invertebrate hosts and, therefore, significant
coadaptation is attainable for arboviruses in spite of host cycling.
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